Cargando…
IL-6 and other biomarkers as predictors of severity in COVID-19
OBJECTIVE: Cytokine release syndrome is suggested to be the most important mechanism triggering acute respiratory distress syndrome and end organ damage in COVID-19. The severity of disease may be measured by different biomarkers. METHODS: We studied markers of inflammation and coagulation as record...
Autores principales: | Broman, N., Rantasärkkä, K., Feuth, T., Valtonen, M., Waris, M., Hohenthal, U., Rintala, E., Karlsson, A., Marttila, H., Peltola, V., Vuorinen, T., Oksi, J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7935117/ https://www.ncbi.nlm.nih.gov/pubmed/33305624 http://dx.doi.org/10.1080/07853890.2020.1840621 |
Ejemplares similares
-
Early administration of tocilizumab in hospitalized COVID-19 patients with elevated inflammatory markers; COVIDSTORM—a prospective, randomized, single-centre, open-label study
por: Broman, Niklas, et al.
Publicado: (2022) -
Association of human myxovirus resistance protein A with severity of COVID-19
por: Lehtinen, Otto, et al.
Publicado: (2022) -
Rapid implementation of home oxygen treatment and remote monitoring for COVID-19 patients at the verge of the Omicron wave in Turku, Finland
por: Hänninen, Janne, et al.
Publicado: (2023) -
‘Early administration of tocilizumab in hospitalized COVID-19 patients with elevated inflammatory markers; COVIDSTORM’ – Author's reply
por: Broman, Niklas, et al.
Publicado: (2022) -
Tuberculosis in Kidney Transplant Recipients: A Nationwide Cohort in a Low Tuberculosis Incidence Country
por: Feuth, Thijs, et al.
Publicado: (2023)